Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Chronic conditions, late mortality, and health status after childhood AML: a Childhood Cancer Survivor Study report

Lucie M. Turcotte, Jillian A. Whitton, Wendy M. Leisenring, Rebecca M. Howell, Joseph P. Neglia, Rachel Phelan, Kevin C. Oeffinger, Kirsten K. Ness, William G. Woods, E. Anders Kolb, Leslie L. Robison, Gregory T. Armstrong, Eric J. Chow

Blood (2023) 141 (1): 90–101.

https://doi.org/10.1182/blood.2022016487

Published: 2023

Includes: Supplemental data

Journal Articles

The Cost of Cellular Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia: A Commercial Insurance Claims Database Analysis

Alex Hoover, Paige Reimche, Dave Watson, Mike Finch, Laura Gilchrist, Lynn Tanner, Yoav H. Messinger, Lucie M Turcotte

Blood (2022) 140 (Supplement 1): 7913–7914.

https://doi.org/10.1182/blood-2022-159895

Published: 2022

Journal Articles

Donor Socioeconomic Status As a Predictor of Altered Immune Function and Treatment Response Following Hematopoietic Cell Transplantation for Hematologic Malignancy

Lucie M Turcotte, Tao Wang, Kirsten M Beyer, Steve W Cole, Stephen R. Spellman, Mariam Allbee-Johnson, Eric Williams, Yuhong Zhou, Michael R Verneris, Jennifer M Knight

Blood (2021) 138 (Supplement 1): 843.

https://doi.org/10.1182/blood-2021-146668

Published: 2021

Journal Articles

Cost of Pediatric Acute Lymphoblastic Leukemia Care in the Current Treatment Era

Lucie M Turcotte, Caleb Hocutt, Yoav H. Messinger, Laura Gilchrist, Dave Watson, Mike Finch

Blood (2021) 138 (Supplement 1): 663.

https://doi.org/10.1182/blood-2021-146621

Published: 2021

Journal Articles

Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation

Shernan Holtan, MD, Todd E. DeFor, MS, Armin Rashidi, MD PhD, Alexander Khoruts, MD, Christopher Staley, PhD, Lucie M Turcotte, MD, Pamala A. Jacobson, PharmD, Daniel J. Weisdorf, MD, Margaret L. MacMillan, MD

Blood (2019) 134 (Supplement_1): 39.

https://doi.org/10.1182/blood-2019-129236

Published: 2019

Journal Articles

Socioeconomic Status Is Associated with Prognostic Factors in Childhood Acute Lymphoblastic Leukemia - Implications for Outcomes: A Report from the Children's Oncology Group

Taumoha Ghosh, Michaela Richardson, MPH, Logan G. Spector, PhD, Lucie M Turcotte, MD

Blood (2019) 134 (Supplement_1): 3808.

https://doi.org/10.1182/blood-2019-125091

Published: 2019

Journal Articles

Chronic Health Conditions and Late Mortality Among Survivors of Childhood Acute Myeloid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS)

Lucie M Turcotte, MD, John A Whitton, MS, Wendy M. Leisenring, ScD, Todd Gibson, PhD, Rebecca M Howell, PhD, Kevin R. Krull, PhD, Joseph P. Neglia, MD MPH, Kevin C Oeffinger, MD, Kirsten K. Ness, PhD, William G. Woods, MD, E. Anders Kolb, MD, Leslie L. Robison, PhD, Gregory T Armstrong, MD, Eric J Chow, MD MPH

Blood (2019) 134 (Supplement_1): 1315.

https://doi.org/10.1182/blood-2019-123477

Published: 2019

Journal Articles

Monocyte Subpopulation Recovery and Outcomes Following Hematopoietic Cell Transplantation

Lucie M. Turcotte, MD, Qing Cao, MS, Elias Krahn, Julie Curtsinger, PhD, Ashley M. Yingst, MS, Sarah Cooley, MD, Claudio G Brunstein, MD, Margaret L. MacMillan, MD, Shernan G. Holtan, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2016) 128 (22): 2232.

https://doi.org/10.1182/blood.V128.22.2232.2232

Published: 2016

Journal Articles

Increased Relapse Associated with Mixed Donor-Donor Chimerism Following Double Umbilical Cord Blood Transplantation (dUCBT)

Michael R. Verneris, MD, Lucie M. Turcotte, MD, Qing Cao, MS, Margaret L. MacMillan, MD, Jeffrey S. Miller, MD, Daniel Weisdorf, MD, Claudio G Brunstein, MD, John E. Wagner, MD

Blood (2012) 120 (21): 358.

https://doi.org/10.1182/blood.V120.21.358.358

Published: 2012

NARROW

Chronic conditions, late mortality, and health status after childhood AML: a Childhood Cancer Survivor Study report

The Cost of Cellular Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia: A Commercial Insurance Claims Database Analysis

Donor Socioeconomic Status As a Predictor of Altered Immune Function and Treatment Response Following Hematopoietic Cell Transplantation for Hematologic Malignancy

Cost of Pediatric Acute Lymphoblastic Leukemia Care in the Current Treatment Era

Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation

Socioeconomic Status Is Associated with Prognostic Factors in Childhood Acute Lymphoblastic Leukemia - Implications for Outcomes: A Report from the Children's Oncology Group

Chronic Health Conditions and Late Mortality Among Survivors of Childhood Acute Myeloid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS)

Monocyte Subpopulation Recovery and Outcomes Following Hematopoietic Cell Transplantation

Increased Relapse Associated with Mixed Donor-Donor Chimerism Following Double Umbilical Cord Blood Transplantation (dUCBT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only